共 232 条
[1]
Mueller M(2004)Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC Antimicrob Agents Chemother 48 369-377
[2]
de la Pena A(2005)Pharmacokinetic/pharmacodynamic evaluation of anti-infective agents Expert Rev Anti Infect Ther 3 361-373
[3]
Derendorf H(2004)Antimicrobial pharmacodynamics: critical interactions of ’bug and drug’ Nat Rev Microbiol 2 289-300
[4]
Schuck EL(2005)Dose adjustment of ciprofloxacin in renal failure: reduce the dose or prolong the administration interval Eur J Med Res 10 145-148
[5]
Derendorf H(2005)Evaluating ciprofloxacin dosing for Pseudomonas aeruginosa infection by using clinical outcome-based Monte Carlo simulations Antimicrob Agents Chemother 49 4009-4014
[6]
Drusano GL(1994)Mechanism-based pharmacodynamic modeling Clin Pharmacol Ther 56 356-358
[7]
Czock D(1996)Dosage regimens of antibacterials Clin Drug Invest 11 229-239
[8]
Rasche FM(2005)Pharmacodynamic modeling of ciprofloxacin resistance in Staphylococcus aureus Antimicrob Agents Chemother 49 209-219
[9]
Zelenitsky S(1998)Comparisons between antimicrobial pharmacodynamic indices and bacterial killing as described by using the Zhi model Antimicrob Agents Chemother 42 1731-1737
[10]
Ariano R(1997)pharmacokinetic–pharmacodynamic modeling of the in vitro antiinfective effect of piperacillin-tazobactam combinations Int J Clin Pharmacol Ther 35 426-433

